Literature DB >> 6139419

Changes in the amino acid content of nerve endings (synaptosomes) induced by drugs that alter the metabolism of glutamate and gamma-aminobutyric acid.

J W Geddes, J D Wood.   

Abstract

The study was centered on the changes in the amino acid content of nerve endings (synaptosomes) induced by drugs that alter the metabolism of glutamate or gamma-aminobutyric acid (GABA), and that possess convulsant or anticonvulsant properties. The onset of seizures induced by various convulsant agents was associated with a decreased content of GABA and an increased content of glutamate in synaptosomes. The concurrent administration of pyridoxine prevented both the biochemical changes and the convulsions. The administration of gabaculine to mice resulted in large increases in the GABA content of synaptosomes that were counteracted by decreases in glutamate, glutamine, and aspartate levels such that the total content of the four amino acids remained unchanged. The administration of aminooxyacetic acid (0.91 mmol/kg) resulted initially in seizure activity, but subsequently in an anticonvulsant action. No simple relationship existed between the excitable state of the brain induced by aminooxyacetic acid and the changes in the synaptosomal levels of any of the amino acid transmitters. A hypothesis was, however, formulated that explained the convulsant-cum-anticonvulsant action of aminooxyacetic acid on the basis of compartmentation of GABA within the nerve endings.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6139419     DOI: 10.1111/j.1471-4159.1984.tb09691.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  27 in total

1.  Time course of effects of 3-mercaptopropionic acid on GABA levels in different brain regions in guinea pigs: possible relationship with associated cardiovascular changes.

Authors:  N L Alsip; J A DiMicco
Journal:  Neurochem Res       Date:  1992-05       Impact factor: 3.996

2.  Osmolarity-sensitive release of free amino acids from cultured kidney cells (MDCK).

Authors:  R Sánchez Olea; H Pasantes-Morales; A Lázaro; M Cereijido
Journal:  J Membr Biol       Date:  1991-04       Impact factor: 1.843

3.  Demonstration of neuron-glia transfer of precursors for GABA biosynthesis in a co-culture system of dissociated mouse cerebral cortex.

Authors:  Renata Leke; Lasse K Bak; Arne Schousboe; Helle S Waagepetersen
Journal:  Neurochem Res       Date:  2008-08-16       Impact factor: 3.996

4.  Changes in the amounts of amino acids associated with nerve endings (synaptosomes) during synaptogenesis.

Authors:  C D Helgason; J D Wood
Journal:  Neurochem Res       Date:  1989-04       Impact factor: 3.996

5.  Regulation of the GABAA receptor/ion channel complex by intracellular GABA levels.

Authors:  J D Wood; M Davies
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

6.  Effect of diabetes on levels and uptake of putative amino acid neurotransmitters in rat retina and retinal pigment epithelium.

Authors:  C Vilchis; R Salceda
Journal:  Neurochem Res       Date:  1996-10       Impact factor: 3.996

7.  Evaluation of the osmoregulatory function of taurine in brain cells.

Authors:  W Walz; A F Allen
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

8.  Evidence for the presence of a benzodiazepine receptor binding substance in cerebrospinal fluid of a rabbit model of hepatic encephalopathy.

Authors:  K D Mullen; J V Martin; W B Mendelson; K Kaminsky-Russ; E A Jones
Journal:  Metab Brain Dis       Date:  1989-12       Impact factor: 3.584

9.  Caffeine-induced changes in the composition of the free amino acid pool of the cerebral cortex.

Authors:  M Portolés; M D Miñana; A Jordá; S Grisolía
Journal:  Neurochem Res       Date:  1985-07       Impact factor: 3.996

10.  Region- and age-dependent alterations of glial-neuronal metabolic interactions correlate with CNS pathology in a mouse model of globoid cell leukodystrophy.

Authors:  Tore Wergeland Meisingset; Alessandra Ricca; Margherita Neri; Ursula Sonnewald; Angela Gritti
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-24       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.